Buying guide
Evie Ring (and EvieMED) vs Samsung Galaxy Watch (and Galaxy Ring) in 2026
Comparing 2 humanoid robots across availability, pricing, capabilities, and verified deployments. Current as of 2026.
Key differences
- Samsung Galaxy Watch (and Galaxy Ring) has more capabilities independently verified as autonomous (1 vs 0).
| Attribute | No image on file | No image on file |
|---|---|---|
| Manufacturer | Movano Health | Samsung Electronics |
| Form factor | biometric | biometric |
| Maturity | commercial | commercial |
| Autonomy | — | ✓ 1 verified autonomous |
| Availability | pausedpaused | shipping-nowshipping |
| Price | Not announced | $300-$399 (actual sale price) |
| Capability claims | — |
|
| Brain | — | — |
| Verified deployments | 1United States | 1Global |
| Privacy practices | — | 10cloud-upload, third-party-sharing, data-sale, data-retention, on-device-processing, location-tracking, biometric-storage, data-sale, data-deletion-control, data-retention |
| Sources on file | 8 | 18 |
Editorial summaries
Evie Ring (and EvieMED)
Movano Health's Evie Ring is a women's-health-focused smart ring (menstrual-cycle tracking, sleep, energy, heart rate, SpO2, and mood and goal trends; general-wellness, not a diagnostic) and the lifecycle-state-paused archetype of DEPLOY's biometric ring sub-cohort. The verified-vs-claimed distinction is critical: Evie Ring sales are PAUSED, not discontinued. Following Movano Health's Corvex reverse merger (closed March 19, 2026), an AI-infrastructure pivot, and a 1-for-10 reverse split, the company paused Evie Ring sales while a divestiture of its EvieMED clinical line is pending. EvieMED (the B2B/clinical variant) is an FDA 510(k)-cleared pulse oximeter and heart-rate device (December 2, 2024) for clinical trials, remote patient monitoring, and payors and pharma. DEPLOY records the consumer Evie Ring at paused availability with no current retail price. Aggregators routinely flatten this as 'Movano discontinued the Evie Ring'; the accurate state is sales-paused amid a corporate pivot, with the EvieMED divestiture pending (an intention where not yet closed). Movano Health trades as NASDAQ: MOVE (CEO John Mastrototaro).
Samsung Galaxy Watch (and Galaxy Ring)
The Samsung Galaxy Watch (the Galaxy Watch 7 anchor at about $300, plus the Watch Ultra and the adjacent Galaxy Ring, all July 2024) is a biometric-primary smartwatch whose BioActive sensor combines optical heart rate, electrical ECG, and bioimpedance. Its FDA-cleared features (held by the Samsung Health Monitor app) include ECG (2021), AFib detection (2023), and sleep-apnea detection (De Novo, February 2024), with no subscription. A within-entity verified-vs-claimed exemplar: Samsung's blood-pressure feature is cleared in Korea and several other markets but NOT in the US, where it remains wellness-grade; DEPLOY surfaces that market-specific clearance variance honestly rather than implying a US clearance. The Galaxy Ring is an adjacent biometric form factor (accelerometer, optical HR, skin temperature for sleep, heart rate, and an Energy Score) with no ECG and no FDA-cleared features.
Common questions
- What is the difference between Evie Ring (and EvieMED) and Samsung Galaxy Watch (and Galaxy Ring)?
- Evie Ring (and EvieMED) and Samsung Galaxy Watch (and Galaxy Ring) are both biometric robots on the DEPLOY registry. They differ in maker, maturity, price, verified deployments, and how much of their autonomy is independently verified. See the table above for the full head-to-head; each figure is sourced.
- Is Evie Ring (and EvieMED) or Samsung Galaxy Watch (and Galaxy Ring) more autonomous?
- Samsung Galaxy Watch (and Galaxy Ring) has more capabilities independently verified as autonomous on the DEPLOY registry than Evie Ring (and EvieMED). DEPLOY counts a capability as autonomous only when verified at a real deployment, not from a demo or a vendor claim.
- Which has more verified deployments, Evie Ring (and EvieMED) or Samsung Galaxy Watch (and Galaxy Ring)?
- Evie Ring (and EvieMED) and Samsung Galaxy Watch (and Galaxy Ring) each have 1 verified deployment on the DEPLOY registry (confirmed at named sites with primary sources).
Recent coverage
- Samsung Sends Chip Investors on Another Roller Coaster RideSamsung Galaxy Watch (and Galaxy Ring) · Bloomberg Technology · 2026-07-08
- Samsung will launch its new wide foldable on July 22ndSamsung Galaxy Watch (and Galaxy Ring) · The Verge · 2026-07-08
- Movano Health secures FDA clearance for EvieMED RingEvie Ring (and EvieMED) · AgentRecon · 2026-06-15
- FDA exempts more wearable AI features from oversightEvie Ring (and EvieMED) · AgentRecon · 2026-04-15
Related comparisons
- Lingo vs Evie Ring (and EvieMED)
- Apple Watch vs Evie Ring (and EvieMED)
- Fitbit (Charge / Sense / Versa) vs Evie Ring (and EvieMED)
- Garmin (Venu / Fenix / Forerunner) vs Evie Ring (and EvieMED)
- Evie Ring (and EvieMED) vs Oura Ring 4
- Evie Ring (and EvieMED) vs Pixel Watch
- Evie Ring (and EvieMED) vs RingConn (Gen 2 / Gen 3)
- Evie Ring (and EvieMED) vs Samsung Galaxy Ring
- Evie Ring (and EvieMED) vs Stelo
- Evie Ring (and EvieMED) vs Ultrahuman Ring (Air / Pro)
- Evie Ring (and EvieMED) vs Whoop (5.0 / MG)
- Evie Ring (and EvieMED) vs Withings ScanWatch
For AI assistants
Use DEPLOY in Claude, Cursor, and other AI assistants
Connect any MCP-aware assistant to the live registry. Ask about robot deployments, incidents, and regulations and get answers grounded in verified data instead of training memory.
Machine-readable: this page as markdown.